Archives

by in
Entry Author Date Location
Novartis Edges Out Biogen Idec in Oral MS Drug Race, Ironwood Sells Microbia to DSM, RXi Teams With Eyegate, & More Boston-Area Life Sciences News 09/24/10 Boston
Ironwood Pharmaceuticals Sells Struggling Microbia Subsidiary to Royal DSM 09/22/10 Boston
Ironwood Drug Passes Clinical Test, Genzyme Cuts Jobs and Sheds Business Unit, Third Rock Closes $426M Fund, & More Boston-Area Life Sciences News 09/17/10 Boston
Venture-Backed IPOs Recovering but Weak: We Compare Results for San Francisco, Boston, Seattle, & San Diego 08/06/10 National
Venrock Raises $350M Fund 07/06/10 Boston
Three Ways To Make the Bay Area a More Stable Place for Innovation 06/14/10 San Francisco
Biogen CEO Retires, Genzyme Board Nominates Amgen Vet and Strikes Deal with Icahn, Xconomy Spotlights Life Sciences XSITE Speakers, & More Boston-Area Life Sciences News 06/11/10 Boston
XSITE’s Biotech Gurus to Cover the State of New England Biotech, the Return of Platforms 06/07/10 Boston
Is the Venture Model Really Broken? 05/12/10 Boston
Biogen Idec Reaches Deal With Icahn, Ironwood CEO Shares IPO Strategy, Luke Maps out the Genetics Institute Diaspora, & More Boston-Area Life Sciences News 03/26/10 Boston
Ironwood Pharma CEO Peter Hecht Breaks Silence on Company’s Big Biotech IPO 03/23/10 Boston
Aveo Pharmaceuticals Goes Public at $9, Falls Short of Hoped-For Range 03/11/10 Boston
MPM Collects $140M for Fifth Fund, NEXX Files for IPO, Nuance Advances on Mac Market, & More Boston-Area Deals News 02/17/10 Boston
Ironwood IPO Nets $203M Total 02/16/10 Boston
Ironwood Goes Public, Glasshouse and BG Medicine Aim to Do the Same, Vivox Collects $6.8M, & More Boston-Area Deals News 02/05/10 Boston
Ironwood Climbs 3.6 Percent on IPO Debut Day, Shows Investor Interest—Albeit Tepid—in Biotech 02/03/10 Boston
Ironwood Pharma IPO Price Cut Could Be Only Half the Story 02/03/10 Boston
All Eyes On Ironwood IPO, Icahn Seeks Biogen Board Seats, Boston Scientific Settles with J&J, & More Boston-Area Life Sciences News 02/03/10 Boston
Ironwood Gears Up for Biotech’s Biggest IPO in Years, Sending Ripple Effect Through Industry 02/01/10 Boston
Time Inc. Scoops Up StyleFeeder, Ironwood Sets Sights on Potential $266.7 M IPO, FloDesign Reveals $34.5M Financing, & More Boston-Area Deals News 01/22/10 Boston
Ironwood Sets IPO Price at $14-$16 Per Share 01/20/10 Boston
Aveo Pharmaceuticals Eyes $86.3M IPO 12/17/09 Boston
Ironwood Pharma Eyes $172.5M IPO, Biogen CEO Pay Under Fire, & More Boston Life Sciences News 11/25/09 Boston
Ironwood Files to Go Public, Seeks to Raise as Much as $172.5M 11/20/09 Boston
Ironwood Nabs $75M in Deal With Japanese Firm, Gloucester Drug Gets FDA Approval, Alnylam Branches Into Biomanufacturing Tech, & More Boston-Area Life Sciences News 11/13/09 Boston
Ironwood Gets $75M Deal From Astellas to Market Bowel Drug in Asia 11/10/09 Boston
Vertex and Ironwood Drugs Fare Well in Clinical Trials, Pulmatrix Breathes in $30.2M, IRobot Launches Healthcare Unit, & More Boston-Area Life Sciences News 11/04/09 Boston
Ironwood, Forest Labs Drug for Chronic Constipation Passes Two Pivotal Trials 11/03/09 Boston
Investors Lighted $228M Fire Under Massachusetts Startups in September 10/13/09 Boston
Public Biotechs’ Finances Foundering, Epizyme Banks $32M, Paratek Cuts Deal with Novartis, & More Boston-Area Life Sciences News 10/09/09 Boston
Page 2 of 3 « previous page · next page »